Aspira Women's Health Inc. - Common Stock, $0.001 par value (AWHL)
CUSIP: 04537Y208
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 42,091,923
- Total 13F shares
- 1,395,854
- Share change
- -607,540
- Total reported value
- $2,079,102
- Price per share
- $1.49
- Number of holders
- 26
- Value change
- -$907,130
- Number of buys
- 13
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 04537Y208?
CUSIP 04537Y208 identifies AWHL - Aspira Women's Health Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04537Y208:
Top shareholders of AWHL - Aspira Women's Health Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Robert H. Drysdale |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,310,531
|
$4,416,489 | — | 28 Nov 2023 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
2.7%
|
1,157,000
|
$3,586,700 | — | 31 Mar 2024 | |
| James T. LaFrance |
3/4/5
|
Director |
—
mixed-class rows
|
606,434
mixed-class rows
|
$2,024,931 | — | 31 Mar 2022 | |
| Robert D. Auerbach |
3/4/5
|
Director |
—
mixed-class rows
|
375,462
mixed-class rows
|
$1,228,683 | — | 09 Feb 2023 | |
| Ruby Sharma |
3/4/5
|
Director |
—
mixed-class rows
|
358,961
mixed-class rows
|
$1,176,328 | — | 09 Feb 2023 | |
| Valerie Barber Palmieri |
3/4/5
|
Executive Chair, Director |
—
class O/S missing
|
267,088
|
$900,087 | — | 16 May 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.66%
|
277,407
|
$859,962 | — | 31 Mar 2024 | |
| B. Riley Wealth Advisors, Inc. |
13F
|
Company |
0.3%
|
125,374
|
$672,005 | — | 31 Mar 2024 | |
| Robert Harry Beechey |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
150,000
|
$480,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.15%
|
62,766
|
$194,575 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
59,544
|
$184,638 | — | 31 Mar 2024 | |
| Torsten Hombeck |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
55,000
mixed-class rows
|
$181,610 | — | 13 May 2024 | |
| Quantum Private Wealth, LLC |
13F
|
Company |
0.12%
|
52,418
|
$162,496 | — | 31 Mar 2024 | |
| Veronica Gh Jordan |
3/4/5
|
Director |
—
class O/S missing
|
41,620
|
$140,259 | — | 25 Jul 2023 | |
| Minh Hoang Merchant |
3/4/5
|
General Counsel and Secretary |
—
mixed-class rows
|
37,865
mixed-class rows
|
$125,735 | — | 14 Feb 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.08%
|
33,335
|
$103,338 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
29,354
|
$90,998 | — | 31 Mar 2024 | |
| Marlene McLennan |
3/4/5
|
Interim Chief Financial Office |
—
class O/S missing
|
25,000
|
$80,000 | — | 01 Dec 2022 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.06%
|
25,438
|
$78,858 | — | 31 Mar 2024 | |
| Northeast Financial Consultants Inc |
13F
|
Company |
0.06%
|
23,436
|
$72,652 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
18,249
|
$56,572 | — | 31 Mar 2024 | |
| M&T BANK CORP |
13F
|
Company |
0.04%
|
14,999
|
$46,497 | — | 31 Mar 2024 | |
| Ryan Thinh Phan |
3/4/5
|
CSO & COO |
—
class O/S missing
|
3,939
|
$13,274 | — | 24 Jul 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,446
|
$10,683 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
2,422
|
$7,508 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
2,077
|
$6,439 | — | 31 Mar 2024 | |
| Castleview Partners, LLC |
13F
|
Company |
0%
|
1,316
|
$4,080 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,049
|
$3,252 | — | 31 Mar 2024 | |
| Operose Advisors LLC |
13F
|
Company |
0%
|
1,000
|
$3,100 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
906
|
$2,809 | — | 31 Mar 2024 | |
| Fernwood Investment Management, LLC |
13F
|
Company |
0%
|
666
|
$2,065 | — | 31 Mar 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
119
|
$369 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
51
|
$158 | — | 31 Mar 2024 |
Institutional Holders of Aspira Women's Health Inc. - Common Stock, $0.001 par value (AWHL) as of Q2 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.